Immunotherapy clinical trials and Sue Scott’s story

About Cervical Cancer

Cervical cancer is the sixth cancer prevalent among women.

One of the main causes for the disease is the Human Papilloma Virus, HPV, which causes warts on the female genitalia.

The Gardasil vaccine is used against the Papilloma virus with the goal to prevent infection with women, and the vaccine itself is given to both girls and boys and women up to age 45… to read more>>

Sue Scott’s story

In 2011 Sue Scott became ill with cervical cancer. She chose a different option to fight the disease and joined a clinical trial. In an exciting post published today (December 2017), she tells how she defeated the metastatic disease which is currently in full remission.

Sue has been awarded one of the most advanced treatments in the world, based on genetic engineering of immune cells.

To view the moving video, click on the link:

To check if our service suits your case
We need to talk

Improve therapeutic outcomes, prolong life and quality of life, is our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics